عنوان

Therapeutics in Cardiology

شابک

9400913338

شابک

9789400913332

شماره

b556469

عنوان اصلي

Therapeutics in Cardiology

نام عام مواد

[Book]

نام نخستين پديدآور

edited by A. Bayés Luna, A. Betriu, G. Permanyer.

محل نشرو پخش و غیره

Dordrecht

نام ناشر، پخش کننده و غيره

Springer Netherlands

تاریخ نشرو بخش و غیره

1988

نام خاص و کميت اثر

(700 pages)

عنوان فروست

Developments in cardiovascular medicine, 81.

متن يادداشت

1. Severe Arrhythmias and Sudden Death --;1.1 Introduction --;1.2 Influence of circadian rhythm on the electrophysiological properties of the human heart --;1.3 Sudden arrhythmic death --;picture of the possible candidate --;1.4 Sudden death in cardiomyopathies --;1.5 Sudden death in the Wolff-Parkinson-White syndrome --;1.6 Conclusions --;2. The Pharmacological Treatment of Severe Arrhythmias --;2.1 Introduction --;2.2 Torsades de pointe --;2.3 Non-invasive assessment of antiarrhythmic drugs --;2.4 An electrophysiological approach to drug therapy of ventricular arrhythmias --;2.5 Application of plasma level determinations to antiarrhythmic drug management --;2.6 Amiodarone as drug of first choice in the prevention of sustained ventricular tachycardia (VT) and/or ventricular fibrillation (VF) --;2.7 Conclusions --;3. The Surgical Treatment of the Arrhythmias --;3.1 Introduction --;3.2 The role of left stellectomy in the prevention of lethal arrhythmias --;3.3 Surgical treatment of the cardiac arrhythmias --;3.4 Early experience in endocardial fulguration for the treatment of ventricular tachycardia --;3.5 The implantable cardioverter-defibrillator --;3.6 Conclusions --;4. Pacemakers --;4.1 Introduction --;4.2 Electrophysiological studies in patients with syncope of unknown cause --;4.3 Tachylog P43 in the control of tachyarrhythmias --;4.4 Control of the pacemaker patient --;4.5 Conclusions --;5. Arterial Hypertension --;5.1 Introduction --;5.2 The value of treatment in the prevention of hypertension complications --;5.3 Use of?-adrenergic blocking agents in arterial hypertension --;5.4 Other antihypertensive drugs --;5.5 Problems in the treatment of chronic primary arterial hypertension --;5.6 Conclusions --;6. Heart Failure --;6.1 Introduction --;6.2 Patients with heart failure and normal sinus rhythm: who should receive digitalis? --;6.3 Vasodilators in the treatment of congestive heart failure --;6.4 The new inotropic agents --;6.5 Right ventricular failure in ischaemic heart disease --;6.6 Conclusions --;7. Heart-Lung Transplantation --;7.1 Introduction --;7.2 Transplantation of the heart and lungs --;7.3 Heart transplantation --;8. Valvulopathies --;8.1 Introduction --;8.2 Bioprosthesis versus mechanical devices --;8.3 Conservative mitral valve surgery --;8.4 Chronic valvular heart disease: timing of surgery --;8.5 Diagnosis of prosthetic dysfunction by means of echocardiography and Doppler ultrasound --;8.6 Conclusions --;9. Surgical Correction of Tetralogy of Fallot: Mid-Term Results --;9.1 Introduction --;9.2 Mid-term postoperative cardiac catheterization studies after corrective surgery for tetralogy of Fallot --;9.3 Mid- and long-term postoperative results of tetralogy of Fallot cases operated on in the Hospital Infantil, Ciudad Sanitaria 'Vall d'Hebron' (1971-1983) --;9.4 Cardiac dysrhythmias after surgical treatment of tetralogy of Fallot --;9.5 Tetralogy of Fallot: present status of corrective surgery and midterm follow-up --;10. Angina Pectoris (I) --;10.1 Introduction --;10.2 Coronary reserve and angina therapy --;10.3 Nitrates in the treatment of angina pectoris --;10.4 Comparison of four calcium antagonists with placebo and propranolol --;10.5 Pathophysiology of unstable angina pectoris: clinical, angiographic and therapeutic observations --;10.6 Treatment of primary angina --;10.7 Conclusions --;11. Angina Pectoris (II): Instrumental Procedures --;11.1 Introduction --;11.2 Current status of coronary angioplasty in Spain --;11.3 Coronary angioplasty: a new way to revascularization of the heart --;11.4 Long-term results of coronary artery bypass graft surgery: experience of the Montreal Heart Institute --;11.5 The Netherlands coronary surgery study (N.C.S.): coronary bypass surgery in patients with mild angina pectoris --;11.6 Laser treatment of coronary artery disease --;11.7 Conclusions --;12. Myocardial Infarction (I) --;12.1 Introduction --;12.2 Recanalization of coronary arteries by thrombolytic agents in acute myocardial infarction --;12.3 Rupture of the free ventricular wall during the acute phase of myocardial infarction: diagnosis and treatment --;12.4 Myocardial revascularization with acute myocardial infarction --;12.5 Twenty-five years of Coronary Units: perspectives for the future --;12.6 Thrombolysis in acute myocardial infarction --;12.7 Conclusions --;13. Myocardial Infarction (II): Primary and Secondary Prevention --;13.1 Introduction --;13.2 How, when and who to treat for dyslipemia --;13.3 Prophylactic?-blocking treatment after myocardial infarction --;13.4 Criticism of long-term preventive treatment after myocardial infarction --;13.5 Strategies for postinfarction treatment --;13.6 Conclusions --;Index of Subjects.

متن يادداشت

In the last years the Spanish Society of Cardiology has shown a great interest in the continuous medical education in cardiology. We would like to thank the Spanish Society of Cardiology and the Catalan Cardiac Society for the generous assistance they have given us during all stages of book preparation.

موضوع مستند نشده

Cardiology.

موضوع مستند نشده

Medicine.

شماره رده

نشانه اثر

مستند نام اشخاص تاييد نشده

edited by A. Bayés Luna, A. Betriu, G. Permanyer.

مستند نام اشخاص تاييد نشده

A Bayés Luna

مستند نام اشخاص تاييد نشده

A Betriu

مستند نام اشخاص تاييد نشده

G Permanyer

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y